These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11920288)

  • 1. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.
    Goldstein ST; Alter MJ; Williams IT; Moyer LA; Judson FN; Mottram K; Fleenor M; Ryder PL; Margolis HS
    J Infect Dis; 2002 Mar; 185(6):713-9. PubMed ID: 11920288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of acute hepatitis B--United States, 1990-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jan; 52(51-52):1252-4. PubMed ID: 14704650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for acute viral hepatitis--United States, 2005.
    Wasley A; Miller JT; Finelli L;
    MMWR Surveill Summ; 2007 Mar; 56(3):1-24. PubMed ID: 17363893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.
    Mele A; Mariano A; Tosti ME; Stroffolini T; Pizzuti R; Gallo G; Ragni P; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2007 Feb; 44(3):e17-24. PubMed ID: 17205431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hepatitis B among children and adolescents--United States, 1990-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1015-8. PubMed ID: 15525899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two community hepatitis B outbreaks: an argument for vaccinating incarcerated persons.
    Devasia RA; Jones TF; Kainer MA; Halford S; Sheeler LL; Swift J; Schaffner W
    Vaccine; 2006 Feb; 24(9):1354-8. PubMed ID: 16297510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hepatitis B in the era of immunisation: pitfalls in the identification of high risk patients.
    Rosner G; Lurie Y; Blendis L; Halpern Z; Oren R
    Postgrad Med J; 2006 Mar; 82(965):207-10. PubMed ID: 16517803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination coverage among adults--United States, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 May; 55(18):509-11. PubMed ID: 16691181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis B and C risk factors in Germany--results of the national surveillance].
    Walter J; Radun D; Claus H; Hamouda O; Stark K
    Gesundheitswesen; 2005 Jul; 67(7):441-7. PubMed ID: 16103966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B in Poland in 2007].
    Rosińska M; Czarkowski MP
    Przegl Epidemiol; 2009; 63(2):245-50. PubMed ID: 19799254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
    Mele A; Stroffolini T; Zanetti AR
    J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hepatitis B virus infection.
    Mahoney FJ; Burkholder BT; Matson CC
    Am Fam Physician; 1993 Mar; 47(4):865-74. PubMed ID: 8438685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B vaccination and changes in sexual risk behaviour among men who have sex with men in Amsterdam.
    Xiridou M; Wallinga J; Dukers-Muijers N; Coutinho R
    Epidemiol Infect; 2009 Apr; 137(4):504-12. PubMed ID: 18631424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.